[1]
Tabish, S.A. Is Diabetes Becoming the Biggest Epidemic of the Twenty-first Century? Int. J. Health Sci. (Qassim), 2007, 1(2), V-VIII.
[2]
Wild, S.; Roglic, G.; Green, A.; Sicree, R.; King, H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care, 2004, 27(5), 1047-1053.
[3]
Lipsky, B.A.; Berendt, A.R.; Cornia, P.B.; Pile, J.C.; Peters, E.J.G.; Armstrong, D.G.; Deery, H.G.; Embil, J.M.; Joseph, W.S.; Karchmer, A.W.; Pinzur, M.S.; Senneville, E. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin. Infect. Dis., 2012, 54(12), e132-e173.
[4]
Malaguarnera, G.; Gagliano, C.; Salomone, S.; Giordano, M.; Bucolo, C.; Pappalardo, A.; Drago, F.; Caraci, F.; Avitabile, T.; Motta, M. Folate status in type 2 diabetic patients with and without retinopathy. Clin. Ophthalmol., 2015, 9, 1437-1442.
[5]
Carratalà, J.; Rosón, B.; Fernández-Sabé, N.; Shaw, E.; del Rio, O.; Rivera, A.; Gudiol, F. Factors associated with complications and mortality in adult patients hospitalized for infectious cellulitis. Eur. J. Clin. Microbiol. Infect. Dis., 2003, 22(3), 151-157.
[6]
Zervos, M.J.; Freeman, K.; Vo, L.; Haque, N.; Pokharna, H.; Raut, M.; Kim, M. Epidemiology and outcomes of complicated skin and soft tissue infections in hospitalized patients. J. Clin. Microbiol., 2012, 50(2), 238-245.
[7]
Lipsky, B.A.; Tabak, Y.P.; Johannes, R.S.; Vo, L.; Hyde, L.; Weigelt, J.A. Skin and soft tissue infections in hospitalised patients with diabetes: culture isolates and risk factors associated with mortality, length of stay and cost. Diabetologia, 2010, 53(5), 914-923.
[8]
Malaguarnera, G.; Gagliano, C.; Bucolo, C.; Vacante, M.; Salomone, S.; Malaguarnera, M.; Leonardi, D.G.; Motta, M.; Drago, F.; Avitabile, T. Lipoprotein(a) serum levels in diabetic patients with retinopathy. BioMed Res. Int., 2013, 2013943505
[9]
Jääskeläinen, I.H.; Hagberg, L.; From, J.; Schyman, T.; Lehtola, L.; Järvinen, A. Treatment of complicated skin and skin structure infections in areas with low incidence of antibiotic resistance-a retrospective population based study from Finland and Sweden. Clin. Microbiol. Infect., 2016, 22(4), 383.e1-383.e10.
[10]
Barbagallo, F.; Latteri, S.; Sofia, M.; Ricotta, A.; Castello, G.; Chisari, A.; Randazzo, V.; La Greca, G. Appendicular tuberculosis: the resurgence of an old disease with difficult diagnosis. World J. Gastroenterol., 2010, 16(4), 518-521.
[11]
Malaguarnera, G.; Gagliano, C.; Giordano, M.; Salomone, S.; Vacante, M.; Bucolo, C.; Caraci, F.; Reibaldi, M.; Drago, F.; Avitabile, T.; Motta, M. Homocysteine serum levels in diabetic patients with non proliferative, proliferative and without retinopathy. BioMed Res. Int., 2014, 2014191497
[12]
Blanes, J.I.M. Consensus document on treatment of infections in diabetic foot. Rev. Esp. Quimioter., 2011, 24(4), 233-262.
[13]
Chisari, E.M.; Lo Castro, T.; Grasso, A.; Chisari, C.G.; Di Nuovo, S.; Chisari, G. Functional stress and microbiota eye in subjects with type 2 diabetes: a multifactorial approach. Acta Med. Mediter., 2017, 33, 9-16.
[14]
Malaguarnera, G.; Giordano, M.; Cappellani, A.; Berretta, M.; Malaguarnera, M.; Perrotta, R.E. Skin cancers in elderly patients. Anticancer. Agents Med. Chem., 2013, 13(9), 1406-1411.
[15]
Chisari, G.; Chisari, E.M.; Borzì, A.M.; Chisari, C.G. Amniotic menbrane use in type 2 diabetes patients with chronic ulcers: microbiological evaluation and therapeutic benefits. Acta Med. Mediter., 2017, 33, 431.
[16]
Pennisi, M; Bertino, G; Gagliano, C; Malaguarnera, M; Bella, R; Borzì, AM; Madeddu, R; Drago, F Malaguarnera, G Resveratrol in
Hepatitis C Patients Treated with Pegylated-Interferon-ƒ¿-2b and
Ribavirin Reduces Sleep Disturbance. Nutrients 2017. 18;9(8)
[17]
Heinzelmann, M.; Scott, M.; Lam, T. Factors predisposing to bacterial invasion and infection. Am. J. Surg., 2002, 183(2), 179-190.
[18]
Rhoads, D.D.; Wolcott, R.D.; Percival, S.L. Biofilms in wounds: management strategies. J. Wound Care, 2008, 17(11), 502-508.
[19]
Stevens, D.L.; Bisno, A.L.; Chambers, H.F.; Dellinger, E.P.; Goldstein, E.J.C.; Gorbach, S.L.; Hirschmann, J.V.; Kaplan, S.L.; Montoya, J.G.; Wade, J.C. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin. Infect. Dis., 2014, 59(2), 147-159.
[20]
Chisari, G.; Chisari, E.M.; Francaviglia, A.; Chisari, C.G. The mixture of bifidobacterium associated with fructo-oligosaccharides reduces the damage of the ocular surface. Clin. Ter., 2017, 168(3), e181-e185.
[21]
Malaguarnera, G.; Vacante, M.; Drago, F.; Bertino, G.; Motta, M.; Giordano, M.; Malaguarnera, M. Endozepine-4 levels are increased in hepatic coma. World J. Gastroenterol., 2015, 21(30), 9103-9110.
[22]
Chisari, G.; Chisari, E.M.; Borzì, A.M.; Chisari, C.G. Aging eye microbiota in Dry Eye Syndrome in patients treated with Enterococcus faecium and Saccharomyces boulardii. Curr. Clin. Pharmacol., 2017, 12(2), 99-105.
[23]
Chisari, G.; Rampello, L.; Chisari, E.M.; Catania, V.E.; Greco, C.; Stagni, E.; Chisari, C.G. Microbiology synergism between tear substitutes and symbiotic treatment of patients with irritable bowel syndrome. Acta Med. Mediter., 2016, 32, 463.
[24]
Malaguarnera, M.; Vacante, M.; Condorelli, G.; Leggio, F.; Di Rosa, M.; Motta, M.; Malaguarnera, G.; Alessandria, I.; Rampello, L.; Chisari, G. Probiotics and prebiotics in the management of constipation in the elderly. Acta Med. Mediter., 2013, 29(4), 791-798.
[25]
Chisari, G.; Greco, C.; Chisari, E.M.; Chisari, C.G.; Rampello, L.; Rampello, L. Microbiological characteristics of the ocular surface in the patients with discoid lupus erythematosus. Acta Med. Mediter., 2015, 31, 1057-1062.
[26]
Chisari, C.G.; Greco, C.; Chisari, E.M.; Rampello, L.; Chisari, G. The ocular surface in the Discoid Lupus Erythematosus. Acta Med. Mediter., 2015, 31, 1217-1221.
[27]
Latteri, S.; Malaguarnera, G.; Mannino, M.; Pesce, A.; Currò, G.; Tamburrini, S.; Scuderi, M. Ultrasound as point of care in management of polytrauma and its complication. J. Ultrasound, 2017, 20(2), 171-177.
[28]
Malaguarnera, M.; Motta, M.; Vacante, M.; Malaguarnera, G.; Caraci, F.; Nunnari, G.; Gagliano, C.; Greco, C.; Chisari, G.; Drago, F.; Bertino, G. Silybin-vitamin E-phospholipids complex reduces liv-er fibrosis in patients with chronic hepatitis C treated with pegylated interferon α and Ribavirin. Am. J. Transl. Res., 2015, 7(11), 2510-2518.
[29]
Chisari, G.; Stagni, E.; Rampello, L.; Malaguarnera, M.; Chisari, C.G. The ocular surface in patients video Display Terminal (VDT). Acta Med. Mediter., 2013, III, 369-373.
[30]
Stock, S.J.; Kelly, R.W.; Riley, S.C.; Calder, A.A. Natural antimicrobial production by the amnion. Am. J. Obstet. Gynecol., 2007, 196(3), 1-6.
[31]
Malaguarnera, G.; Bertino, G.; Chisari, G.; Motta, M.; Vecchio, M.; Vacante, M.; Caraci, F.; Greco, C.; Drago, F.; Nunnari, G.; Malaguarnera, M. Silybin supplementation during HCV therapy with pegylated interferon-α plus ribavirin reduces depression and anxiety and increases work ability. BMC Psychiatry, 2016, 16(1), 398.
[32]
Frazzetto, P.; Vacante, M.; Malaguarnera, M.; Vinci, E.; Catalano, F.; Cataudella, E.; Drago, F.; Malaguarnera, G.; Basile, F.; Biondi, A. Depression in older breast cancer survivors. BMC Surg., 2012, 12(1)(Suppl. 1), S14.
[33]
Agarwal, N.; Hanumunthadu, D.; Afrasiabi, M.; Malaguarnera, G.; Cordeiro, M.F. Clinical update in optic nerve disorders. Expert Rev. Ophthalmol., 2015, 10(2), 145-166.
[34]
Azuara-Blanco, A.; Pillai, C.T.; Dua, H.S. Amniotic membrane transplantation for ocular surface reconstruction. Br. J. Ophthalmol., 1999, 83(4), 399-402.
[35]
Lo, V.; Pope, E. Amniotic membrane use in dermatology. Int. J. Dermatol., 2009, 48(9), 935-940.
[36]
Fincke, B.G.; Miller, D.R.; Christiansen, C.L.; Turpin, R.S. Variation in antibiotic treatment for diabetic patients with serious foot infections: a retrospective observational study. BMC Health Serv. Res., 2010, 10, 193.
[37]
Chisari, E.M.; Chisari, C.G.; Di Nuovo, S.; Chisari, G. Functional stress and alteration of the surface in subjects video display terminal (VDT). Acta Med. Mediter., 2016, 32, 1577.
[38]
Uccello, M.; Malaguarnera, G.; Pelligra, E.M.; Biondi, A.; Basile, F.; Motta, M. Lipoprotein(a) as a potential marker of residual liver function in hepatocellular carcinoma. Indian J. Med. Paediatr. Oncol., 2011, 32(2), 71-75.
[39]
Malaguarnera, G.; Catania, V.E.; Francaviglia, A.; Malaguarnera, M.; Drago, F.; Motta, M.; Latteri, S. Lipoprotein(a) in patients with hepatocellular carcinoma and portal vein thrombosis. Aging Clin. Exp. Res., 2017, 29(Suppl. 1), 185-190.
[40]
Malaguarnera, G; Latteri, S; Catania, VE; Malaguarnera, M Reduction
of cardiovascular risk in subjects with high lipoprotein(a) levels.
Journ. Thor. Disease, 2017. 2332-2336.
[41]
Meller, D.; Pauklin, M.; Thomasen, H.; Westekemper, H.; Steuhl, K-P. Amniotic membrane transplantation in the human eye. Dtsch. Arztebl. Int., 2011, 108(14), 243-248.
[42]
Mamede, A.C.; Carvalho, M.J.; Abrantes, A.M.; Laranjo, M.; Maia, C.J.; Botelho, M.F. Amniotic membrane: from structure and functions to clinical applications. Cell Tissue Res., 2012, 349(2), 447-458.
[43]
Cabrera-Pastor, A.; Malaguarnera, M.; Taoro-Gonzalez, L.; Llansola, M.; Felipo, V. Extracellularc GMP modulates learning biphasically by modulating glycinereceptors, CaMKII and glutamate-nitricoxide-cGMPpathway. Sci. Rep., 2016, 6, 33124.
[44]
Niknejad, H.; Peirovi, H.; Jorjani, M.; Ahmadiani, A.; Ghanavi, J.; Seifalian, A.M. Properties of the amniotic membrane for potential use in tissue engineering. Eur. Cell. Mater., 2008, 15, 88-99.
[45]
Jenkins, T.C.; Knepper, B.C.; Jason Moore, S.; Saveli, C.C.; Pawlowski, S.W.; Perlman, D.M.; McCollister, B.D.; Burman, W.J. Comparison of the microbiology and antibiotic treatment among diabetic and nondiabetic patients hospitalized for cellulitis or cutaneous abscess. J. Hosp. Med., 2014, 9(12), 788-794.
[46]
Shah, B.R.; Hux, J.E. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care, 2003, 26(2), 510-513.
[47]
Boulton, A.J.; Vileikyte, L.; Ragnarson-Tennvall, G.; Apelqvist, J. The global burden of diabetic foot disease. Lancet, 2005, 366(9498), 1719-1724.
29
3
1
1